Efficacy of interventions designed to inhibit the progression of coronary atherosclerosis

Diabetes Research and Clinical Practice

Volumn 30, Issue SUPPL. 1, 1996, Pages

  Macka, Wendy J ^a   Hodis, Howard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Carotid ultrasonography; Clinical trials; Coronary angiography; Coronary atherosclerosis; Interventions

Indexed keywords

ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; NICARDIPINE;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

CAROTID ARTERIES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0029869344     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(96)80037-4     Document Type: Article

References (40)

1. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study
2. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts
3. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
4. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
5. Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures: a comparison of different measures of treatment effect
6. Coronary angiographic changes with lovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS)
7. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative angiography: The Canadian Coronary Atherosclerosis Intervention Trial
8. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
9. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
10. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
11. Can lifestyle changes reverse coronary heart disease?
12. Regular physical exercise and low-fat diet: effects on progression of coronary artery disease
13. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS)
14. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP)
15. Retardation of angiographic progression of coronary artery disease by nifedipine: results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT)
16. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis
17. Precision and reproducibility of quantitative coronary angiography with applications to controlled clinical trials a sampling study
18. Arterial imaging and atherosclerosis reversal
19. Natural antioxidant vitamins reduce coronary artery lesion progression as assessed by sequential coronary angiography
20. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: lipid and nonlipid factors
21. Triglycefide- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of Iovastatin
22. Changes in sequential coronary arteriograms and subsequent coronary events
23. Prognostic significance of progression of coronary atherosclerosis
24. Coronary progression predicts future cardiac events
25. Beneficial effects of colestipol-niacin on coronary atherosclerosis: a 4-year follow-up
26. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging
27. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: a new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects
28. Determinants of carotid intima-media thickness: a population-based ultra-sonography study in eastern Finnish men
29. Risk factors for early carotid atherosclerosis in middle-aged French women
30. Beneficial effects of colestipol-niacin therapy on the common carotid artery: two- and four-year reduction of intima-media thickness measured by ultrasound
31. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study
32. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis
33. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease
34. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease
35. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images
36. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol-niacin therapy
37. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
38. PLAC-2: effects of pravastatin on progression of carotid atherosclerosis and clinical events
39. B-mode ultrasound assessment of the treatment effect of pravastatin on the progression of carotid and femoral intima-media thickness in a population selected on coronary disease
40. Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) design features